CR20220112A - Composiciones que comprenden tigolaner para el control de parásitos - Google Patents
Composiciones que comprenden tigolaner para el control de parásitosInfo
- Publication number
- CR20220112A CR20220112A CR20220112A CR20220112A CR20220112A CR 20220112 A CR20220112 A CR 20220112A CR 20220112 A CR20220112 A CR 20220112A CR 20220112 A CR20220112 A CR 20220112A CR 20220112 A CR20220112 A CR 20220112A
- Authority
- CR
- Costa Rica
- Prior art keywords
- tigolaner
- compositions
- controlling parasites
- parasites
- controlling
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N53/00—Biocides, pest repellants or attractants, or plant growth regulators containing cyclopropane carboxylic acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/15—Depsipeptides; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Abstract
La presente invención se refiere a una composición que comprende tigolaner y, opcionalmente, agentes endoparasiticidas, un método para su fabricación y su uso como un medicamento para el control de parásitos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP19191727 | 2019-08-14 | ||
PCT/EP2020/072640 WO2021028479A1 (en) | 2019-08-14 | 2020-08-12 | Compositions comprising tigolaner for controlling parasites |
Publications (1)
Publication Number | Publication Date |
---|---|
CR20220112A true CR20220112A (es) | 2022-06-21 |
Family
ID=67658818
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR20220112A CR20220112A (es) | 2019-08-14 | 2020-08-12 | Composiciones que comprenden tigolaner para el control de parásitos |
Country Status (17)
Country | Link |
---|---|
US (1) | US20220331314A1 (es) |
EP (1) | EP4013388A1 (es) |
JP (1) | JP2022544537A (es) |
KR (1) | KR20220054319A (es) |
CN (1) | CN114698369A (es) |
AU (1) | AU2020328863A1 (es) |
BR (1) | BR112022002623A2 (es) |
CA (1) | CA3147171A1 (es) |
CO (1) | CO2022002898A2 (es) |
CR (1) | CR20220112A (es) |
EC (1) | ECSP22012650A (es) |
IL (1) | IL290597A (es) |
MX (1) | MX2022001764A (es) |
TW (1) | TW202122079A (es) |
UY (1) | UY38841A (es) |
WO (1) | WO2021028479A1 (es) |
ZA (1) | ZA202202672B (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PE20231205A1 (es) | 2020-05-29 | 2023-08-17 | Boehringer Ingelheim Animal Health Usa Inc | Compuestos heterociclicos como anthelminticos |
WO2022268813A1 (en) | 2021-06-24 | 2022-12-29 | Syngenta Crop Protection Ag | Insect, acarina and nematode pest control |
WO2023105064A1 (en) * | 2021-12-10 | 2023-06-15 | Syngenta Crop Protection Ag | Insect, acarina and nematode pest control |
WO2023105065A1 (en) * | 2021-12-10 | 2023-06-15 | Syngenta Crop Protection Ag | Insect, acarina and nematode pest control |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE211466T1 (de) | 1992-03-17 | 2002-01-15 | Fujisawa Pharmaceutical Co | Depsipeptide, herstellung und anwendung |
DE4400464A1 (de) | 1994-01-11 | 1995-07-13 | Bayer Ag | Endoparasitizide Mittel |
DE10008128A1 (de) | 2000-02-22 | 2001-08-23 | Bayer Ag | Endoparasitizide Mittel |
DE102004020721A1 (de) | 2004-04-28 | 2005-11-24 | Bayer Healthcare Ag | Dermal applizierbare flüssige Formulierungen zur Bekämpfung von parasitierenden Insekten an Tieren |
DE102005011779A1 (de) | 2005-03-11 | 2006-09-14 | Bayer Healthcare Ag | Endoparasitizide Mittel |
DE102006061538A1 (de) | 2006-12-27 | 2008-07-03 | Bayer Healthcare Ag | Kombinationsprodukt zur Bekämpfung von Parasiten an Tieren |
WO2014012975A1 (en) | 2012-07-19 | 2014-01-23 | Bayer Cropscience Ag | Process for the preparation of 5-fluoro-1h-pyrazoles |
KR102191469B1 (ko) | 2013-02-06 | 2020-12-16 | 바이엘 애니멀 헬스 게엠베하 | 해충 방제제로서의 할로겐-치환된 피라졸 유도체 |
CN105934429B (zh) | 2013-11-27 | 2022-03-04 | 拜耳动物保健有限责任公司 | 制备5-氟-1h-吡唑的方法 |
WO2015078847A1 (en) | 2013-11-27 | 2015-06-04 | Bayer Cropscience Ag | Process for the preparation of 5-fluoro-1h-pyrazoles |
WO2015150302A1 (en) | 2014-04-01 | 2015-10-08 | Bayer Cropscience Ag | Process for the preparation of n-[3-(benzylcarbamoyl)phenyl]-1 h-pyrazole-5-carboxamides |
TWI694066B (zh) | 2014-05-27 | 2020-05-21 | 德商拜耳動物保健有限公司 | 始於六氟丙烯之製備5-氟-1h-吡唑的方法 |
MX369501B (es) | 2014-08-19 | 2019-11-11 | Bayer Animal Health Gmbh | Proceso para la preparación de 5-fluoro-1h-pirazoles partiendo de hexafluoropropeno. |
WO2016177619A1 (en) | 2015-05-05 | 2016-11-10 | Syngenta Participations Ag | Method of control of stinkbugs |
AR104691A1 (es) * | 2016-05-18 | 2017-08-09 | Labyes De Uruguay S A | Composición veterinaria de imidacloprid, moxidectina y praziquantel de administración tópica cutánea (spot on) para tratamiento y prevención de las ecto y endoparasitosis que afectan a los perros |
US11344532B2 (en) * | 2017-09-06 | 2022-05-31 | Bayer Animal Health Gmbh | Topically administrable formulation for the control and prevention of animal parasites |
JP2019094270A (ja) * | 2017-11-17 | 2019-06-20 | 日産化学株式会社 | 有害生物防除用組成物及び有害生物の防除方法 |
-
2020
- 2020-08-12 CN CN202080057562.3A patent/CN114698369A/zh active Pending
- 2020-08-12 AU AU2020328863A patent/AU2020328863A1/en active Pending
- 2020-08-12 TW TW109127331A patent/TW202122079A/zh unknown
- 2020-08-12 CA CA3147171A patent/CA3147171A1/en active Pending
- 2020-08-12 EP EP20757856.8A patent/EP4013388A1/en active Pending
- 2020-08-12 WO PCT/EP2020/072640 patent/WO2021028479A1/en unknown
- 2020-08-12 MX MX2022001764A patent/MX2022001764A/es unknown
- 2020-08-12 CR CR20220112A patent/CR20220112A/es unknown
- 2020-08-12 BR BR112022002623A patent/BR112022002623A2/pt unknown
- 2020-08-12 JP JP2022509052A patent/JP2022544537A/ja active Pending
- 2020-08-12 KR KR1020227007837A patent/KR20220054319A/ko unknown
- 2020-08-12 US US17/635,289 patent/US20220331314A1/en active Pending
- 2020-08-14 UY UY0001038841A patent/UY38841A/es unknown
-
2022
- 2022-02-13 IL IL290597A patent/IL290597A/en unknown
- 2022-02-17 EC ECSENADI202212650A patent/ECSP22012650A/es unknown
- 2022-03-04 ZA ZA2022/02672A patent/ZA202202672B/en unknown
- 2022-03-14 CO CONC2022/0002898A patent/CO2022002898A2/es unknown
Also Published As
Publication number | Publication date |
---|---|
CN114698369A (zh) | 2022-07-01 |
AU2020328863A1 (en) | 2022-04-07 |
US20220331314A1 (en) | 2022-10-20 |
ZA202202672B (en) | 2023-05-31 |
WO2021028479A1 (en) | 2021-02-18 |
IL290597A (en) | 2022-04-01 |
MX2022001764A (es) | 2022-08-04 |
ECSP22012650A (es) | 2022-03-31 |
KR20220054319A (ko) | 2022-05-02 |
CO2022002898A2 (es) | 2022-04-19 |
TW202122079A (zh) | 2021-06-16 |
UY38841A (es) | 2021-02-26 |
EP4013388A1 (en) | 2022-06-22 |
CA3147171A1 (en) | 2021-02-18 |
BR112022002623A2 (pt) | 2022-05-03 |
JP2022544537A (ja) | 2022-10-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2022001764A (es) | Composiciones que comprenden tigolaner para el control de parasitos. | |
LT3577110T (lt) | 8-oksetan-3-il-3,8-diazabiciklo[3.2.1]oktan-3-ilo pakeistieji junginiai, kaip živ inhibitoriai | |
SG10201908839QA (en) | 2,4-dihydroxy-nicotinamides as apj agonists | |
AU2015279424A8 (en) | Difluoromethyl-nicotinic-indanyl carboxamides | |
MX2019011496A (es) | Composiciones de niraparib. | |
PH12019502851A1 (en) | New azaquinoline derivatives | |
MX2017011711A (es) | Mejora en o con relacion a compuestos organicos. | |
MX2022010755A (es) | Inhibidores de quinasa y usos de los mismos. | |
MX2017008390A (es) | Uretanos funcionalizados con alcoxisilano y funcionalizados con alofanato. | |
MY177933A (en) | Herbicidal composition comprising quizalofop-p | |
WO2018127612A3 (en) | Compositions comprising lespedeza plant extract | |
IL284800A (en) | Methods, uses and compositions | |
EP3760195A4 (en) | COMPOSITION WITH 2,3-BUTANEDIOL AS THE ACTIVE SUBSTANCE | |
MX2017007955A (es) | Formas solidas que comprenden (1e, 4e)-2-amino-n,n-dipropil-8-(4-( pirrolidina-1-carbonil)fenil)-3h-benzo[b]azepina-4-carboxamida, composiciones de las mismas y usos de las mismas. | |
MY152388A (en) | Composition and method for controlling plant diseases | |
GB201915828D0 (en) | Compounds, compositions and therapeutic uses thereof | |
MX2016013439A (es) | Formas solidas de un compuesto farmaceuticamente activo. | |
MX2020003598A (es) | Composicion de material de revestimiento a base de yeso para moldeo y metodo de fabricacion de composicion de material de revestimiento a base de yeso para moldeo. | |
EP3610869A4 (en) | COMPOSITION CONTAINING SARPOGRELATE AS AN ACTIVE INGREDIENT, FOR THE PREVENTION OR TREATMENT OF NEUROSENSORY HEARING LOSS | |
MX2022007663A (es) | Tieniloxazolonas y analogos. | |
CR20220292A (es) | Tiofenocarboxamidas sustituidas y sus derivados | |
EP4052761A4 (en) | PERFUME COMPOSITION | |
EP3998327A4 (en) | PERFUME COMPOSITION | |
MX2019000977A (es) | Composiciones farmacéuticas a base de curcumina y procedimientos para su fabricación. | |
MX2018008730A (es) | Metodos y composiciones para el control de las hormigas cultivadoras de hongos. |